We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > viral diseases

News List

AbbVie, Harvard University collaborate for research on emergent viral diseases expresspharma
August 31, 2020
This collaboration aims to rapidly integrate fundamental biology into the preclinical and clinical development of new therapies for viral diseases that address a variety of therapeutic modalities.
Ology Bioservices Inks $27M DoD Deal contractpharma
April 26, 2020
To adapt Veroplex cell platform for rapid response to viral threats for Department of Defense.
Ascletis Pharma to develop Alphamab’s viral diseases drug in China pharmaceutical-technology
January 16, 2019
Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment of viral diseases such as hepatitis B in Greater China....
Emergex Enters into MoU with Brazil’s Fiocruz to Develop Novel Vaccines Against Viral Diseases pharmafocusasia
December 03, 2018
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious .....
New uses for existing antiviral drugs biospectrumasia
April 28, 2018
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses…